Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study (Q33551425)

28 July 2017

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study (English)

1 reference

28 July 2017

1 reference

11

1 reference

28 July 2017

37

1 reference

28 July 2017

Georgia Chenevix-Trench

62

Georgia Chenevix-Trench

0 references

Montserrat García-Closas

36

Montserrat García-Closas

0 references

Kunle Odunsi

38

Aleksandra Gentry-Maharaj

Kunle Odunsi

0 references

55

Aleksandra Gentry-Maharaj

0 references

Michael S Anglesio

Michael S Anglesio

60

0 references

Martin Köbel

Martin Köbel

2

0 references

Anna deFazio

Anna deFazio

5

0 references

David Bowtell

David D Bowtell

4

0 references

Estrid Høgdall

Estrid Høgdall

7

0 references

Usha Menon

Usha Menon

13

0 references

Susan J. Ramus

Susan J Ramus

67

0 references

Susanne Krüger Kjaer

Susanne Krüger Kjær

25

0 references

Blaise A Clarke

Blaise A Clarke

12

0 references

Paul D P Pharoah

64

Paul D P Pharoah

1 reference

28 July 2017

9

Nicolas Wentzensen

1 reference

28 July 2017

33

Louise A Brinton

1 reference

28 July 2017

26

Allan Jensen

1 reference

28 July 2017

32

Julie M Cunningham

1 reference

28 July 2017

63

Alice S Whittemore

1 reference

28 July 2017

10

Kirsten B Moysich

1 reference

28 July 2017

56

Simon A Gayther

1 reference

28 July 2017

29

Brooke L Fridley

1 reference

28 July 2017

65

Ellen L Goode

1 reference

28 July 2017

31

Robert A Vierkant

2 references

ORCID Public Data File 2021

28 July 2017

Amit Oza

52

1 reference

ORCID Public Data File 2021

Kimberly R Kalli

28

Kimberly R Kalli

1 reference

28 July 2017

1

Weiva Sieh

1 reference

28 July 2017

22

Michael E Carney

1 reference

28 July 2017

61

Sharon E Johnatty

1 reference

28 July 2017

27

Claus Høgdall

1 reference

28 July 2017

47

Valerie McGuire

1 reference

28 July 2017

48

Joseph H Rothstein

1 reference

28 July 2017

20

Galina Lurie

1 reference

28 July 2017

50

Marcus Q Bernardini

1 reference

28 July 2017

40

Shashikant Lele

1 reference

28 July 2017

57

Anna V Tinker

1 reference

28 July 2017

6

Marc T Goodman

1 reference

28 July 2017

30

Gary L Keeney

1 reference

28 July 2017

Lara Sucheston-Campbell

42

Lara Sucheston

1 reference

28 July 2017

66

David G Huntsman

1 reference

28 July 2017

14

C Blake Gilks

1 reference

28 July 2017

3

Teri A Longacre

1 reference

28 July 2017

8

Suha Deen

1 reference

28 July 2017

17

Sian Fereday

1 reference

28 July 2017

24

Rayna K Matsuno

1 reference

28 July 2017

35

Mark E Sherman

1 reference

28 July 2017

Mercedes Jimenez-Linan

43

Mercedes Jimenez-Linan

1 reference

28 July 2017

45

Jennifer Alsop

1 reference

28 July 2017

58

Leah M Prentice

1 reference

28 July 2017

59

Christine Chow

1 reference

28 July 2017

19

Laura Galletta

1 reference

28 July 2017

16

Jason Madore

1 reference

28 July 2017

21

Lynne R Wilkens

1 reference

28 July 2017

23

Pamela J Thompson

1 reference

28 July 2017

Andre Kim

15

1 reference

28 July 2017

Joshy George

18

1 reference

28 July 2017

Hannah P Yang

34

1 reference

28 July 2017

Carl Morrison

39

1 reference

28 July 2017

Wiam Bshara

41

1 reference

28 July 2017

Kristy Driver

44

1 reference

28 July 2017

Marie Mack

46

1 reference

28 July 2017

Barry P Rosen

49

1 reference

28 July 2017

Helen Mackay

51

1 reference

28 July 2017

Eva L Wozniak

53

1 reference

28 July 2017

Elizabeth Benjamin

54

1 reference

28 July 2017

9 July 2013

1 reference

Lancet Oncology Commission

28 July 2017

1 reference

28 July 2017

14

1 reference

28 July 2017

9

1 reference

28 July 2017

853-862

1 reference

Integrated genomic characterization of endometrial carcinoma

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Hormone response in ovarian cancer: time to reconsider as a clinical target?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Comprehensive molecular portraits of human breast tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Rethinking ovarian cancer: recommendations for improving outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

The different roles of ER subtypes in cancer biology and therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Assessment of hepatocyte growth factor in ovarian cancer mortality

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

The role of hormonal therapy in gynecological cancers-current status and future directions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

St. Gallen 2011: Summary of the Consensus Discussion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

21 June 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Tamoxifen for relapse of ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Biological determinants of endocrine resistance in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evalu

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Expressions of estrogen and progesterone receptors in epithelial ovarian cancer: a clinicopathologic study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immuno

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Usual adult body mass index is not predictive of ovarian cancer survival.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Common variants in mismatch repair genes and risk of invasive ovarian cancer.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Estrogen receptor α and Sp1 regulate progesterone receptor gene expression

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006367

Steroid hormone receptors and long term survival in invasive ovarian cancer

31 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

7 January 2021

Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

7 January 2021

Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

7 January 2021

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

1 reference

7 January 2021

Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970253-5

7 January 2021

10.1016/S1470-2045(13)70253-5

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference